Clinical Trials Directory

Trials / Completed

CompletedNCT04102345

Lavender vs Zolpidem Sleep Quality During Diagnostic PSG

Lavender vs Zolpidem: Sleep Quality During Diagnostic Polysomnography

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
58 (actual)
Sponsor
HealthPartners Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

In this pragmatic, clinical study the investigators propose that lavender aromatherapy is comparable to Zolpidem (Ambien) in improving the quality of diagnostic sleep studies.

Conditions

Interventions

TypeNameDescription
OTHERLavender AromatherapyCommercially available lavender essential oil and diffuser.
DRUGZolpidemPhysician directed, pre-prescribed. Study team does not prescribe zolpidem.

Timeline

Start date
2019-09-04
Primary completion
2020-11-10
Completion
2020-11-10
First posted
2019-09-25
Last updated
2021-03-17
Results posted
2021-02-24

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04102345. Inclusion in this directory is not an endorsement.